🇺🇸 FDA
Pipeline program

Suzetrigine

VX24-548-113

Approved small_molecule completed

Quick answer

Suzetrigine for Acute Pain is a Approved program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 2 ClinicalTrials.gov record(s).

Program details

Company
VERTEX PHARMACEUTICALS INC / MA
Indication
Acute Pain
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials